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one of the major challenges for translational realization of hiPSC technology. Here we demonstrate a scalable culture system
for hiPSC expansion using the E8 chemically defined and xeno-free medium under either adherent or suspension conditions. To
optimize suspension conditions guided by a computational simulation, we developed a method to efficiently expand hiPSCs as
undifferentiated aggregates in spinner flasks. Serial passaging of two different hiPSC lines in the spinner flasks using the E8
medium preserved their normal karyotype and expression of undifferentiated state markers of TRA-1–60, SSEA4, OCT4, and
NANOG. The hiPSCs cultured in spinner flasks for more than 10 passages not only could be remained pluripotent as indicated by
in vitro and in vivo assays, but also could be efficiently induced toward mesodermal and hematopoietic differentiation.
Furthermore, we established a xeno-free protocol of single-cell cryopreservation and recovery for the scalable production of
hiPSCs in spinner flasks. This system is the first to enable an efficient scale-up bioprocess in completely xeno-free condition for
the expansion and cryopreservation of hiPSCs with the quantity and quality compliant for clinical applications.
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1104 Y. Wang et al.IntroductionHuman pluripotent stem cells (hPSCs), including human induced
pluripotent stem cells (hiPSCs) and human embryonic stem cells
(hESCs) that can differentiate into any mature cell type of the
body, hold great promise for revolutionizing regenerative
medicine. Specifically, the integration-free reprogramming
technologies, such as ones using plasmids, provide a feasible
method to generate autologous and clinical-grade hiPSC lines
for therapeutic applications under current good manufacture
practice (cGMP) conditions. Patient-specific hiPSC lines derived
from postnatal somatic cells (Chou et al., 2011; Dowey et al.,
2012; Ye et al., 2009) exhibit vast potential not only in disease
modeling for pathological studies but also in practical cellular
therapies. These clinical applications require a large number
of hiPSCs or their progenies. For example, an optimized dose
was suggested to contain 4.2 × 108 to 5.6 × 108 CD34+ cells for
hematopoietic stem cell (HSC) transplantation for a 70-kg
adult patient (Mehta et al., 2009). Production of a clinically
relevant quantity of hiPSCs and/or their progenies for specific
applications, sometimes considered as ~1 to 2 billion (Kehoe
et al., 2010), in a chemically defined condition by robust,
reproducible and economic methods remains a major chal-
lenge for advancing hiPSC technology from the bench to the
clinic.
Conventionally, hiPSCs are induced and expanded on
feeder cells as adherent colonies in media containing sera or
serum replacement containing human or animal serum
albumin (Okita et al., 2007; Yu et al., 2007). The involvement
of animal products or sera impedes these culture conditions
to meet the strict requirement of clinical or pre-clinical
utilization because of the uncertainty of complex compo-
nents and the quality variance from batch to batch. Since the
first isolation of hiPSCs, significant improvements in feeder-
and serum-free chemically defined culture medium and
substrates for adherent hiPSC culture have been developed
(Chen et al., 2011; Li et al., 2005; Ludwig et al., 2006; Vallier
et al., 2005; Wang et al., 2007). However, these approaches
involving adherent culture of hiPSCs in Petri dishes still raise
a major hurdle of large scale and well-controlled expansion
for clinical use.
Suspension culture for hiPSC expansion provides a feasible
solution for its scale-up capacity. After a Rho-associated-
coiled-coil kinase (ROCK) inhibitor Y27632 was reported to
permit the survival of dissociated hESCs when supplemented
in the medium only on the first day of seeding (Watanabe et
al., 2007), detailed protocols were established for the
single-cell inoculation and suspension culture of hPSCs as
cell aggregates in a variety of vessel types (Amit et al., 2011;
Olmer et al., 2010; Zweigerdt et al., 2011). Other studies
have also reported successful suspension culture in spinner
flasks in 100-ml vessels (Abbasalizadeh et al., 2012; Chen
et al., 2012; Fluri et al., 2012; Krawetz et al., 2010; Olmer
et al., 2012; Singh et al., 2010; Steiner et al., 2010). Despite
the rapid development of hPSC suspension culture in these
studies, most of the reproducible systems are based on
commercially available serum-free media, StemPro or
mTeSR, which are complex and expensive. The unknown
composition (such as StemPro) and high cost of these media
pose a major concern for developing reproducible methods
for large-scale expansion of hiPSCs.Chen et al. recently reported the development of a
significantly improved hiPSC culture medium, E8, which
contains only seven other completely defined and xeno-free
components supplementing the standard DMEM/F-12 medi-
um (Chen et al., 2011). We did confirm that this significantly
improved medium without the need to add bovine serum
albumin (BSA) Fraction V or human albumin supported the
growth of multiple hiPSC lines under feeder-free conditions
in adhesion. Based on this, we sought to test whether the
significantly simplified E8 medium could support a robust
and economic suspension culture system in a stirred
bioreactor for large-scale expansion and cryopreservation
of hiPSCs. Here, we used two integration-free hiPSC lines,
BC1 and TNC1, which were derived from leukocytes of either
a healthy donor or a sickle cell disease patient using
plasmid-based episomal vectors (Chou et al., 2011). We
began by evaluating the capacity of E8 medium to support
the expansion of hiPSCs in static suspension cultures. We
then optimized the operating protocol for direct adaptation
and expansion of the hiPSCs in spinner flasks using
computational simulation of the hydrodynamic properties
and experimental tests. Furthermore, we tested serial
passaging and differentiation potential of hiPSCs expanded
in spinner flasks. Finally, xeno-free cryopreservation and
recovery methods were established for hiPSCs cultured in
the bioreactor.
Materials and methods
Maintenance of hiPSCs in adhesion
Human iPSC lines BC1 and TNC1 were initially maintained on
mouse embryonic fibroblast (MEF) feeders in standard ESC
medium as previously described (Chou et al., 2011). At
passage 30–32, BC1 cells were dissociated using 0.5 mM EDTA
in calcium- and magnesium-free PBS (Beers et al., 2012), and
directly adapted onto tissue culture plates coated with
Matrigel (MG, 1.67 μg/cm2, BD) or truncated recombinant
human vitronectin (VNT-N, 5 μg/cm2, Invitrogen) in E8
medium (home-made as described by Chen et al. (2011) or
Essential 8 from Invitrogen) supplemented with 10 μM ROCK
inhibitor Y27632 (Stemgent) for 24 h. Medium was changed
daily. Cells were routinely passaged as small clumps using
EDTA method (Beers et al., 2012) or as single cells using
Accutase (Sigma-Aldrich) with the split ratio of 1:8 to 1:12
every 2 to 3 days after reaching 60% to 80% confluence.
Suspension culture of hiPSCs
BC1 and TNC1 were cultured in feeder-free adhesion culture
for at least 5 passages before transfer in suspension culture.
Prior to the passage, hiPSCs were treated with Y27632 for
1 h and dissociated with pre-warmed Accutase for 2 to 3 min
in 37 °C. After gentle pipetting, the single cell solution was
diluted 1:10 with DMEM/F-12, and centrifuged at 200 g for
5 min. Cells were resuspended by adding E8 medium with
10 μM Y27632 and plated at a density of 1.5 × 105 to
2.0 × 105 cells/ml in ultra-low attachment plates or seeded
at 4 × 105 to 5 × 105 cells/ml. Daily medium change was
performed by replacing 70% of the medium with fresh E8
medium without ROCK inhibitor. Cells were cultured in
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100 ml capacity with a single glass-ball stirring pendulum,
Integra Bio-sciences) in standard 5% CO2 incubator at
37 °C and passaged every 3 to 4 days using Accutase as
aforementioned.
Analysis for aggregates and metabolism
Samples of cell aggregates were analyzed for cell number,
viability, and metabolic products. Briefly, 0.5 to 1.5 ml of
samples were taken and placed still for 5 min. Supernatants
were filtered, stored in −20 °C, and tested for glucose,
lactate, and pH in a blood gas analyzer (Radiometer, ABL 710
at Department of Radiology, Johns Hopkins Medical Insti-
tute). Light microscopy images were captured using Axiovert
phase contrast microscope (Zeiss). The total number of cell
aggregates Nagg in a 1-ml sample was analyzed by using
the “Embryoid body analysis” module in Celigo imaging
cytometer (Brooks). The average equivalent diameter of
aggregates d and the size of each aggregate in the sample
were also measured in this analysis. For counting the cell
number in a 1-ml sample Ncell and the cell viability, cell
aggregates were dissociated by Accutase, stained with 0.4%
Trypan blue, and counted by Countess automated cell
counter (Life Technologies). The average cell number per
aggregate N = Ncell / Nagg was calculated in 8 samples
containing aggregates in different average diameters d
from three independent culture cycles. In the plot of N–d
(Fig. 3c), the data points fit best to a 3rd-order polynomial,
defined by having the smallest R2 value comparing to other
fitting functions. Dissolved oxygen (DO) level in the suspen-
sion medium was monitored real-time using a non-invasive




Immunofluorescent staining of hiPSCs in adhesion
See Supplementary methods.
Immunofluorescent staining of cell aggregates in
suspension culture
Whole aggregate staining was performed for immunofluo-
rescence microscopy as described before (Chen et al., 2012).
Fluorescent images of whole cell aggregates were captured
and analyzed by LSM 510 META confocal microscope (Zeiss).
Karyotyping
Karyotype of hiPSCs was examined by a certified cytogenet-
icist using G-banding (300–500 bands) method as previously
described (Chou et al., 2011). At least 20 metaphases were
checked for each sample. For example, the passage number
of BC1 p30 + 21 + 21 (see Fig. 4d) means that the examined
BC1 cells have been cultured for 30 passages on MEF,
followed by 21 passages on VNT-N and 21 passages inbioreactor. For TNC1 p30 + 17 + 19, there have been 30
passages on MEF, 17 passages on Matrigel, and 19 passages in
bioreactor.
In vitro hematopoietic differentiation
Human iPSCs were differentiated into hematopoietic stem
cells (HSCs, CD34+CD45+ cells) using spin-embryoid body
(spin-EB) method in feeder- and serum-free conditions as
described before (Ng et al., 2008, 2005; Yu et al., 2008). The
EBs were harvested on day 14 of differentiation. Single cells
were isolated and analyzed by flow cytometry for the
presence of hematopoietic markers and hematopoietic CFU
assay as previously described (Yu et al., 2008; Zhan et al.,
2004).
In vitro spontaneous differentiation of germ cells
Single cells were seeded in ultra-low-attachment plates
in ESC medium supplemented with 10% fetal bovine serum
(FBS, HyClone) at 3.3 × 105 cells/ml to initiate EB forma-
tion. For iPSCs maintained in suspension in spinner flasks,
cell aggregates were washed, and the entire medium was
changed from E8 to differentiation medium to induce
transformation from cell aggregates to EBs on day 3
after passaging. After 8 days, EBs were transferred onto
gelatin-coated plates and attached. Differentiated cells on
day 12 were stained for fluorescencemicroscopy as described.
Teratoma formation assay
The use of immunocompromised mice for teratoma
formation assay was approved by the Animal Care and Use
Committee in Johns Hopkins University. The assay was
performed as described before (Chou et al., 2011). See
more details in the Supplementary methods.
Cryopreservation and recovery of hiPSCs in suspension
culture
Cell aggregates on day 2 or day 3 were pre-treated with
10 μM Y27632 for 1 h and dissociated into a single cell
suspension with Accutase. After washing with PBS once, cells
were suspended in E8 + 10 μM Y27632 and distributed into
Cryovial aliquots. The same amount of E8 + Y27632 + 20%
(in volume) DMSO cryopreservation medium was added
dropwise. Cells were immediately frozen at −80 °C in
isopropanol freezing containers overnight, and transferred
to liquid nitrogen for storage. For recovery from frozen
stock, the cells were thawed by following standard cell culture
protocol. Single cells were seeded at 5 × 104 cells/cm2
in either Matrigel- or VNT-N-coated 150-cm2 flasks or ultra-
low attachment plates, or at 5 × 105 cells/ml directly in
spinner flasks at agitating speed of 60 rpm. The afore-
mentioned culture and passaging protocols were followed
afterwards.
Computational fluid dynamics (CFD) analysis
See Supplementary methods.
Data presentation and statistics
For flow cytometry analysis, 20,000 events were collected
and analyzed. Selected cell populations were shown as a
percentage among the total gated live cells, based on the
comparison with background staining shown when isotype
controls of corresponding antibodies were used. Data of cell
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lactate concentrations, were collected from at least three
independent repeats (n ≥ 3), and all measurements were
done in duplicates or triplicates to avoid sampling error.
Results were reported as mean ± s.d. if not specified. The
two-tailed Student's t-test or two-way analysis of variance
(two-way ANOVA) was performed with GraphPad Prism 5 for
comparison between two groups or multiple groups, respec-
tively. Significance level was set as *P b 0.05, **P b 0.01,
and ***P b 0.001.Results
Adaptation and robust growth in feeder-free
adhesion culture
To prevent contamination of feeder cells in suspension
culture, we first acclimated hiPSCs expanded in convention-
al mouse embryonic fibroblast (MEF) culture conditions
(Chou et al., 2011) into feeder-free condition. BC1 and
TNC1 were transferred directly to E8 medium (Chen et al.,
2011) on culture plates coated with diluted Matrigel or on
purified recombinant vitronectin (VNT-N) substrate (Chen
et al., 2011). We found that a step-by-step adaptation
process, which is typically associated with other feeder-free
conditions (Bigdeli et al., 2008; Desbordes and Studer, 2013;
Stover and Schwartz, 2011), is not required when we
switched to E8 feeder-free conditions. Culture on either
Matrigel or VNT-N supports robust and long-term culture of
adherent, undifferentiated hiPSCs as a monolayer in adhe-
sion (Supplementary Fig. S1a–e). The hiPSCs were routinely
passaged in single cells (using Accutase) or in small clumps
(by EDTA) (Chen et al., 2011) at a split ratio of 1:8 to 1:12
every 3 to 4 days. They expressed TRA-1–60, SSEA4, OCT4,
and NANOG, which are markers for undifferentiated hPSCs
(Supplementary Fig. S1c–e). After more than 30 passages
cultured in E8 medium and feeder-free conditions, hiPSCs
maintained normal karyotype (Supplementary Fig. S1f).
These hiPSCs were able to form embryoid bodies (EBs) in
vitro containing cells from all three germ layers (Supple-
mentary Fig. S2a), confirming that the hiPSCs retained their
pluripotency. We also examined directed hematopoietic
differentiation of BC1 and TNC1 cultured under the E8
feeder-free conditions for at least 10 passages. Using the
spin-EB method (Ng et al., 2008, 2005; Yu et al., 2008) in
a feeder- and serum-free condition, we found that on day
14, ~25%–80% of the differentiating hiPSCs were CD34+CD45+
characteristic of hematopoietic progenitor cells (HPCs)
(Supplementary Fig. S2b). Moreover, hiPSCs expanded in E8
feeder-free condition showed comparable potential to
generate multiple hematopoietic lineages as hiPSCs expand-
ed in MEF culture conditions in the standard colony-forming
unit (CFU) assay (Yu et al., 2008; Zhan et al., 2004)
(Supplementary Fig. S2c).Serial passaging and expansion in static suspension
culture
It has not been reported whether the significantly simplified
E8medium is sufficient to support the survival and proliferationof undifferentiated hPSCs in suspension culture. Thus our
studies began by establishing a static suspension culture
condition in E8 medium for serial passaging and expansion of
hiPSCs. BC1 cells cultured on E8 feeder-free conditions
(E8-Matrigel or E8-VNT-N) for at least 3 passages were seeded
as a single cell suspension in E8 medium supplemented with
Y27632 on the first day (Watanabe et al., 2007). The cells
survived and formed convex dish-shaped aggregates within
24 h due to the gravity force (Fig. 1a). The size of the cell
aggregates gradually increased corresponding to the cell
number along the culture period. BC1 cells expanded in static
suspension in E8 medium with an average rate of 3.7 ± 0.9 fold
per passage, 3.7 × 106 fold increase in total with N99% of the
cells being TRA-1–60+ after 13 passages (Fig. 1b,c). We also
examined the differentiation potential of expanded cells, using
the spin-EB method (Ng et al., 2008, 2005; Yu et al., 2008). We
found that under the hematopoiesis-inducing condition,
leukocyte-like cells emerged around day 10 (Fig. 1d) with
46.8% ± 1.6% of the cells becoming CD34+CD45+ HPCs (Fig. 1e).
These results indicate that undifferentiated hiPSCs can be
expanded in suspension in E8 medium supplemented with
one-day treatment of Y27632, and retain their differentiation
potential.Initiation of dynamic suspension culture of hiPSCs
Computational fluid dynamics (CFD) analysis of glass-ball
spinner flask
Previous studies suggest that an adaptation of hPSCs ex-
panded in adherent culture to suspension culture in static
conditions is needed prior to inoculation in dynamic sus-
pension culture (Amit et al., 2011; Zweigerdt et al., 2011;
Abbasalizadeh et al., 2012). To support a robust production
of hiPSCs from the bench to a clinical setting, we sought to
adapt the cells directly from feeder-free adhesion culture to
dynamic suspension culture in spinner flasks. A key param-
eter of spinner flasks to control is the agitation forces, which
should be sufficient to ensure homogeneous distribution of
cell aggregates, nutrients and oxygen, but not too severe to
harm the cells. Human PSCs are sensitive to high shear stress
that may cause unexpected cell death (Kehoe et al., 2010;
Abbasalizadeh et al., 2012) and differentiation (Adamo et
al., 2009; Yamamoto et al., 2005). Thus the velocity field
profile and the shear stress distribution in the vessel are
major considerations in the bioreactor design and setting for
suspension culture of hPSCs. Spinner flasks equipped with
pendulum-shaped (glass-ball) impellers were advantageous
compared to other impeller types in previous studies
(Zweigerdt et al., 2011; Yirme et al., 2008) that might be
due to mild shear stress generated by the smooth surface.
Therefore, we chose the CELLSPIN system with a 100-ml
spinner flask equipped with a single glass-ball stirring
pendulum as the platform for hiPSC suspension culture. To
predict the hydrodynamic property, we performed compu-
tational fluid dynamics (CFD) analysis for a 3-D model of the
glass-ball spinner flask (see Supplementary methods). The
physical properties of 37 °C pure water were applied to
approximate the properties of a single cell suspension in E8
medium during the first 12 h after inoculation when the cells
are most vulnerable to high shear stress. The simulation of
the steady-state CFD at agitating speeds of 40 rpm, 60 rpm
Figure 1 Serial passaging of hiPSCs in static suspension in E8 medium. (a) Light microscope image of aggregates after 48 h
post-inoculation of single suspension BC1 cells in ultra-low attachment plates. (b) BC1 cells cultured in E8 medium, expanded in static
suspension culture for 13 passages (45 days, n = 3). (c) Flow cytometry plots (n = 3) of TRA-1–60 expression in hiPSCs after 13
passages in static suspension. (d) Light microscope image of HPC-like single suspending cells emerging around a spin-EB on day 14.
(e) Flow cytometry plots (n = 2) of CD34 and CD45 expression in day-14 spin EBs. NC = negative control. Scale bars = 200 μm.
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was performed. A stable flow profile was found in all agitating
speeds examined without inadequate mixing or large
disturbing turbulence (representatively showing 60 rpm,
Fig. 2a). Highest local Reynolds number, Re, was found at
the small area tracking the rotating pendulum, which in-
creased from laminar flow regime (Re b 1000) to laminar-
turbulent transition regime (1000 b Re b 2000) (O'Connor and
Terry Papoutsakis, 1992; Sucosky et al., 2004) as the agitating
speed increased (Supplementary Fig. S3a). The profile of the
z-direction velocity and the streamline indicated that even at
the lowest agitation speed of 40 rpm, the rotating pendulum
provides appropriate convective flow in the vertical direction
that enhances the mass transfer (Fig. 2b). At the maximum
spinning speed, 75 rpm, the highest shear stress was deter-
mined as 0.152 N/m2 (1.52 dyn/cm2) at the point near the
farthest reach of the glass ball from the spinning axis (Fig. 2c).
This shear stress level is lower than spinner flasks equipped
with other types of impellers, such as pitched-blade impeller
(2–5.2 dyn/cm2, 50–100 rpm) (Cormier et al., 2006) and
paddled impeller (4.5–7.8 dyn/cm2, 80–120 rpm) (Kehoe et
al., 2010; Li et al., 2009), indicating mild hydrodynamic
impact on the cells.
Optimization of agitating speed and cell split interval
BC1 cells cultured in E8-Matrigel condition were used for the
optimization of agitating speed and cell split interval.
Consistent with previous studies (Zweigerdt et al., 2011;
Singh et al., 2010), preliminary experiments using seeding
density lower than 4 × 105 cells/ml showed inconsistent cellsurvival and proliferation (data not shown). Thus, we used
4 × 105 to 5 × 105 cells/ml as the seeding density for all
following experiments. After treatment with ROCK inhibitor
and dissociation, a single cell suspension of BC1 hiPSCs from
feeder-free adhesion culture was directly inoculated into the
spinner flask with 45 ml of E8 + Y27632. Cell growth at
agitating speeds of 40 rpm, 60 rpm, and 75 rpm was com-
pared, and three independent repeats were performed in
each condition (n = 3). Within 24 h, hiPSCs formed spherical
aggregates with diameters of 104.2 ± 44.8 μm, 80.6 ±
20.3 μm, and 60.8 ± 16.5 μm on average in 40 rpm, 60 rpm
and 75 rpm, respectively (Fig. 2d–e). The cell aggregates
gradually increased in size along the culture period reaching
120–300 μm on day 5. This is partially due to aggregate
agglomeration, but mostly due to the expansion of the cells
with 2–3 fold increase after 5-day culture (Fig. 2f–g). These
results further demonstrated significantly higher cell density
(Fig. 2f, P = 0.0188) without compromising cell viability
(Fig. 2g) in hiPSCs cultured in agitation rate of 60 rpm.
Moreover, hiPSCs formed more homogeneous aggregates at
60 rpm compared to hiPSCs cultured in 40 rpm and 75 rpm
(Fig. 2e and Supplementary Fig. S3a). The cell expansion rate
decreased from day 3 to day 4 (Fig. 2f) while the cell viability
varied on day 5 (Fig. 2g). Therefore, we decided to culture the
cells at 60 rpm and split them every 3 to 4 days.
Characterization of hiPSCs in dynamic suspension culture
We continued to characterize BC1 cells cultured in the
spinner flasks for pluripotency associated marker expres-
sion, apoptosis level, and metabolism. We found that N98%
Figure 2 Initiation and optimization of dynamic suspension culture in E8 medium. (a–c) 3-D CFD analysis of the velocity field at
different agitating speeds in 100-ml glass-ball type spinner flasks. (a) Absolute value of velocity vectors of the fluid represented by
heat map on two x–y slices at the agitating speed of 60 rpm. (b) Vertical flow in the bioreactor at 40 rpm. Heat plot on an x–z slice
showed distribution of vertical flow. The sign of the value indicated directions of the vectors. Red solid lines were streamlines of the
velocity field. (c) Heat map of shear stress distribution at the x–y slice. (d–g) Direct adaptation of BC1 cells in dynamic suspension
culture from feeder-free adhesion culture at 40 rpm, 60 rpm, and 75 rpm. (d) Representative images of the cells aggregates on day 1,
day 3, and day 5 after seeded as single cells at different agitating speeds. Scale bars = 200 μm. (e) Box-and-whisker plot of the sizes
of cell aggregates. (f) Growth curves of a 5-day culture in the first passage in spinner flask at 40 rpm, 60 rpm, and 75 rpm. Means ±
s.d., n = 3. *P b 0.05; **P b 0.01; ***P b 0.001. (g) Cell viability along the 5-day culture (n = 3).
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OCT4 after 4 days of culture by flow cytometry analysis
(Fig. 3a). The fluorescent images by confocal microscopy
showed the nuclear expression of OCT4 with membraneFigure 3 Characterization of cell aggregates in spinner flasks. (a,
cultured in spinner flasks. (a) Flow cytometry plot (n = 3) of TRA-
represents isotype control. (b) Confocal microscope images of the im
at the center of z-slice of a cell aggregate on day 3. DAPI stained for
per aggregate to the diameter of the aggregate, means ± s.e.m., n
day 3 aggregates, means ± s.d., n = 3, NC = negative control, PC =
and pH (f) in the media samples. Note: the two data points on the
change, means ± s.d., n = 3. (g) The pO2 level as percentage of thelocalization of SSEA4 in BC1 cell aggregates sampled from
suspension culture on day 3 (Fig. 3b), indicating the
maintenance of the undifferentiated state inside the cell
aggregates. We further found that the cell number perb) Expression of the markers for undifferentiated state in BC1
1–60+, SSEA4+, NANOG+, and OCT4+ cells on day 5. Gray area
munofluorescence staining for OCT4 (in green) and SSEA4 (in red)
nuclei. Scale bar = 100 μm. (c) A fitting curve of the cell number
= 300–2000. (d) Flow cytometry plots (n = 2) of TUNEL assay on
positive control. (e, f) Concentration of glucose and lactate (e)
same day represent the concentration before and after media
O2 saturation in three independent experiments (three colors).
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volume (Fig. 3c). Together with the confocal z-stack images
of cell aggregates, our data suggested an even distribution
of cells throughout the entire aggregate without compact
center or hollow cavity. The rate of apoptosis in the cell
aggregates was found to be 1.56% ± 0.1% (n = 3, Fig. 3d),
indicating no severe programmed cell death due to the
aggregate formation and the dynamic culture. Cell metab-
olism was monitored by measuring the consumption of
glucose, the accumulation of lactate, the change of pH and
the oxygen partial pressure (pO2) in the culture medium. We
found that by replacing 2/3 of the medium daily with
pre-warmed fresh E8, the consumption of glucose did not
exceed 40%. Also, the concentration of lactate was restrict-
ed under 10 mM (Fig. 3e), and the pH dropped to 6.75 by day
5 (Fig. 3f). For real-time monitoring of pO2 in the medium, a
non-invasive O2 sensor and optical fiber probe were
equipped to the bioreactor (Abaci et al., 2012). We show
that the pO2 was kept above 15% (Fig. 3g), indicating
sufficient oxygen supply merely by diffusion through the
gas–liquid interface and convective transport in the medi-
um. These data are consistent with the exponential growth
on the first three days followed by a reduced expansion rate
after day 4 when the cell density reached ~1.5 × 106 cells/
ml (Fig. 2f).Serial passaging and expansion of hiPSCs in
suspension culture
To meet the requirement of scale-up processes for hiPSC
production, serial passaging and extended expansion of BC1
and TNC1 cells cultured in our bioreactor system wereFigure 4 Serial passaging and expansion of hiPSCs in xeno-free co
viability (b) at the end of each passage during the expansion of BC1
NANOG+ cells in the aggregates at the beginning of the suspension cul
and 25). (d) G-banding karyotyping of BC1 and TNC1 after extensive
The TNC1 cell line had been undergone 5 times of freeze–thaw cycltested. Human iPSCs were inoculated into spinner flasks as
mentioned above, cultured for 3 to 4 days, passaged as a
single cell suspension, and re-inoculated at the same con-
ditions. Both BC1 and TNC1 cells were maintained in spinner
flasks for at least 2.5 months with 25 passages. During the
culture period, BC1 showed an average expansion rate of
2.4 ± 0.3 per passage, while TNC1 expanded 3.5 ± 0.5 folds
per passage on average (Fig. 4a), indicating variation of
growth rate in suspension culture between the two different
cell lines. The cells maintained high viability during the
serial passaging in suspension. The overall viability was
92.9% ± 2.1% for BC1 and 95.0% ± 1.6% for TNC1 (Fig. 4b).
Both cell lines were also maintained in their undifferentiat-
ed state, as indicated by 95–100% positive stain of TRA-1–
60, SSEA4, OCT4, and NANOG during the expansion period
(Fig. 4c). Furthermore, BC1 and TNC1 cultured for up to 20
passages in spinner flask (plus at least 20 passages in
feeder-free adhesion culture before transfer to suspension
culture) retained normal karyotypes (Fig. 4d).Differentiation potential of hiPSCs in suspension culture
BC1 and TNC1 hiPSCs cultured in spinner flasks for more than
10 passages were tested for their pluripotency by in vitro
and in vivo differentiation methods. For in vitro assay, by
simply replacing the entire E8 medium with differentiation
medium of day-2 spinner flask suspension culture, BC1 and
TNC1 aggregates transformed into EBs and started spontane-
ous differentiation under the stimulation of 10% serum
(Supplementary Fig. S4). After 8 days in spinner flask followed
by 4 days on gelatin-coated tissue culture plates in differen-
tiation medium, cells of all three germ layers could bendition in bioreactors. (a, b) The expansion fold (a) and the cell
and TNC1. (c) The percentage of TRA-1–60+, SSEA4+, OCT4+, and
ture (passage 0) and along the culture period (passages 6, 13, 19,
culture in spinner flask (see detail in Supplementary methods).
es in suspension culture.
Figure 5 Differentiation potential of hiPSCs after prolonged expansion in bioreactors. (a) Immunofluorescence analysis of in vitro
spontaneous differentiation of day-3 hiPSC aggregates. Germ cell markers (red): alpha-fetoprotein (AFP, endoderm), CD31
(mesoderm), and β-3-tubulin (ectoderm). (b) H&E staining of biopsies of teratoma generated from hiPSCs in immunodeficient mice,
n = 2 for each cell line. Black arrows indicate glandular epithelium. (c) Exemplary microscope images and flow cytometry results
of CD34+CD45+ cells from directed in vitro hematopoietic differentiation. The percentage of CD34+CD45+ cells is presented as mean ±
s.d., n = 3. (d) CFU assay. (i) Representative images of different types of colonies in CFU assay. BFU-E: burst-forming unit-erythroid;
CFU-E: erythroid; CFU-GEMM: granulocyte-erythroid-macrophage-megakaryocyte, CFU-GM: macrophage-granulocyte. The hiPSCs
cultured in spinner flasks (SF) were compared with the parallel feeder-free culture of the same cell line in adhesion (AD). The total
number of CFU was analyzed by the two-tailed Student's t-test, means ± s.d., n = 3. Scale bars: 200 μm.
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1112 Y. Wang et al.detected by immunofluorescent staining of specific markers
(Fig. 5a). In contrast, undifferentiated hiPSCs on day 0 showed
negative staining of all germ markers (data not shown). For in
vivo assay, BC1 and TNC1 harvested from suspension culture in
spinner flasks were injected into immune-deficient mice and
were able to form teratomas containing cells of all germ
layers, including glandular epithelium, chondrocytes, and
neural rosettes (Fig. 5b). Directed hematopoietic differenti-
ation potential was also tested as previously described
(Fig. 5c). Differentiating BC1 and TNC1 cells contained
43.57% ± 4.35% (n = 3) and 43.22% ± 7.13% (n = 3)
CD34+CD45+ HPCs on day 14 of differentiation, respectively.
The CFU assay measuring hematopoietic progenitors showed
that hiPSCs cultured in spinner flasks were able to generate
colonies of different hematopoietic cell lineages. The total
number of CFUs was comparable or significantly larger (P =
0.0307, n = 3) than cells cultured in parallel in adhesion
cultures (Fig. 5d).
Cryopreservation and recovery of hiPSCs in suspension
culture
It has been reported that E8 medium with 10% DMSO can be
used as cryopreservation medium for hPSCs frozen in small
clumps (Beers et al., 2012). However, whether E8-based
freezing medium can support single-cell cryopreservation has
not been reported. As the inclusion of Y27632 in freezing
medium was proven to enhance single cell survival at thaw
(Li et al., 2009), we examined cryopreservation of hiPSCs
harvested from expansion in bioreactors in E8 medium
supplemented with 10% (in volume) DMSO and 10 μM Y27632.
Following at least two weeks of storage in liquid nitrogen, we
thawed the frozen cells in both adhesion and suspension
culture conditions. The viability of the frozen cells upon thaw
was measured as 89% ± 4% for BC1 (n = 3) and 93% ± 2% for
TNC1 (n = 3). Moreover, both BC1 and TNC1 showed good
attachment and typicalmorphology of undifferentiated hiPSCs
on Matrigel or VNT-N (Fig. 6a). The cells reached 80%
confluence after 3 to 4 days in culture and were passaged
routinely hereafter, indicating a rapid recovery and good
adaptation back in adhesion culture. Thawed cells were also
able to survive and form aggregates in both static and dynamic
suspension culture (Fig. 6a). Three protocols for recovery
were tested for the purpose of further expansion in suspen-
sion. Cells were thawed in adhesion (AD), ultra-low attach-
ment plate (UL), or spinner flask (SF) for the first passage, and
then transferred directly to spinner flasks on the next splitting
(AD-SF, UL-SF, and SF, respectively, Fig. 6b). We note that the
first passage after thawing in static or dynamic suspension
culture conditions usually required longer culture period (5 to
6 days) to allow enough cell growth for splitting (Fig. 6b). Cells
regained typical expansion rate at the third passage after
thawing (Fig. 6b) and contained N98% of the population with
positive staining of TRA-1–60, SSEA4, OCT4, and NANOG after
5 passages (Fig. 6c). Cells in AD-SF and UL-SF conditions
showed 2–3-fold higher expansion rate in the first passage
than hiPSCs that were directly thawed in spinner flasks
(Fig. 6b). The spin-EB hematopoietic differentiation of hiPSCs
recovered from UL-SF protocol demonstrated an efficient
differentiation into hematopoietic progenitor cells (Fig. 6d).
Furthermore, hiPSCs were tested for karyotype stability after
sequential freeze–thaw cycles using single-cell cryopreserva-
tion. After more than 5 times of sequential freeze–thawprocess after adapted to completely xeno-free conditions,
including at least 4 times of cryopreservation following UL-SF
protocol, both BC1 and TNC1 after ~70 passages maintained
normal karyotype (Figs. 6e and 4d), indicating a reliable
cryopreservation protocol for hiPSCs throughout their useful
lifespan. This xeno-free cryopreservation and recovery proto-
col completed our bioreactor system, offering opportunities
for large-scale cell growth and banking of hiPSC lines.Discussion
Following the demonstration that a ROCK inhibitor such as
Y27632 permits the survival of single-cell hESCs (Watanabe
et al., 2007), several groups utilized it to establish sus-
pension culture systems for the expansion of hPSCs based on
single-cell inoculation (Amit et al., 2011; Olmer et al., 2010;
Zweigerdt et al., 2011; Abbasalizadeh et al., 2012; Chen
et al., 2012; Fluri et al., 2012; Krawetz et al., 2010; Olmer
et al., 2012; Singh et al., 2010; Steiner et al., 2010).
Zweigerdt et al. and Amit et al. established detailed
protocols for the adaptation and suspension culture of
hPSCs in a variety of vessel types (Amit et al., 2011;
Zweigerdt et al., 2011). Recently, Olmer et al. reported a
high yield culture in a monitored spinner flask with 100-ml
working volume. Up to 2 × 108 of hiPSCs were obtained in a
single run of 7 days (Olmer et al., 2012). Chen et al. showed
long-term culture of hESCs in suspension for at least 20
passages with an average 4.3-fold expansion rate within 3 to
4 days of interval, and demonstrated a complete strategy for
hESC banking under cGMP or cGLP condition (Chen et al.,
2012). Most of these approaches were based on serum-free
media that contain BSA Fraction V or human serum albumin
as the major protein component. The batch-to-batch
variance of this animal-source product led to compromised
defined medium (Chen et al., 2011). Toward this, we first
transferred hPSCs into the newly developed E8 medium on
human vitronectin substrate, to avoid BSA and have a
completely xeno-free condition with low concentration of
protein components. We then demonstrated that E8 medium
(with Y27632 on the first day of seeding) is sufficient to
support hiPSC aggregation and survival, and serial passaging
in the undifferentiated state using static suspension culture.
We next aimed to optimize the protocol for dynamic
suspension culture in spinner flasks. While there are many
experimental and computational studies for assessing the
flow dynamics in spinner flasks equipped with various types
of paddle-shaped impellers (Bilgen and Barabino, 2007;
Collignon et al., 2010; Papoutsakis, 1991; Venkat et al.,
1996; Youn et al., 2006), the relevant analysis for glass-ball
spinner flasks has not been reported. We simulated the
velocity field and shear stress of the flow in the glass-ball
type spinner flask, providing reasonable prediction of the
effect of flow on single cells during the first several hours
after inoculation. Some rational approximations were
applied to simplify the model, such as using the properties
of 37 °C water instead of the unknown data of the medium,
omitting gravity due to its negligible effects on single cells
compared to the agitating force, and ignoring the cell
aggregation due to the complexity it would bring to the
model. Although the model could not estimate the shear
stress on the surface of cell aggregates after emergence, the
Figure 6 Cryopreservation and recovery of hiPSCs cultured in suspension. (a) Morphology of hiPSCs on day 3 after thawing either on
Matrigel or VNT-N coated plates for adhesion culture, or in ultra-low attachment plates (UL) or in spinner flasks (SF) for dynamic
suspension culture, respectively, from single-cell cryopreservation in E8-based freezing medium. Scale bars: 200 μm. (b) The
expansion of hiPSCs from cryopreservation following three protocols. AD-SF or UL-SF: thawing cells in adhesion or in UL, respectively,
and transferred in SF at first splitting. SF: directly thawing cells in spinner flask. The significance of difference between UL-SF and SF
on the first passage after thawing was analyzed by two-tailed Student's t-test, means ± s.d., n = 3. (c) Expression of TRA-1–60,
SSEA4, OCT4, and NANOG at the end of passage 5 following a freeze–thaw cycle as determined by flow cytometry. (d) hiPSCs
recovered from UL-SF protocol at passage 5 after thaw kept the potential to differentiate into CD34+CD45+ HPCs. (e) G-banding
karyotyping of BC1 cells after total 72 passages with 30 passages on MEF, 24 passages on VNT-N, and 18 passages in suspension, and at
least 5 times of freeze–thaw cycles.
1113Scalable expansion of human induced pluripotent stem cellsmethod provides an efficient tool for the design and analysis
of the bioreactors with complex vessel structures or non-
standardized impeller designs (Bilgen and Barabino, 2007;
Venkat et al., 1996). Using CFD analysis, we found a steady
flow in all agitation speeds (i.e. 40 rpm, 60 rpm and
75 rpm). Although small turbulent flow may occur at high
agitating speeds according to the calculation of the local
Reynolds number, the shear stress generated by the glass-
ball impeller is considerably lower than by other types of
impellers. Experimentally, we further found that an agita-
tion speed of 60 rpm supports the formation of homogeneous
cell aggregates, showing significantly higher expansion ratesand relatively better cell viability than the other agitation
speeds. As a comparison, hiPSCs formed relatively large
aggregates on day 1 at 40 rpm, which reduced the potential
of further proliferation due to the diffusion limitation.
Moreover, occasions of undesired aggregate agglomeration,
resulting in aggregates larger than 800 μm, were observed
on later days due to insufficient agitating force (from
Supplementary Fig. S3b). At 75 rpm, cell viability dropped
significantly on day 1, leading to slower recovery and
expansion. Based on these results, the optimal split interval
at 60 rpm was next determined. We noticed a reduction in
cell expansion after day 3 or day 4, which might be due to
1114 Y. Wang et al.the diffusion limitation as cell aggregates grow. It is widely
accepted that the diffusion limitation of oxygen in human
tissue is 100 to 200 μm (Hoeben et al., 2004). Therefore, we
determined to split the cells on day 3 or day 4 when most of
the cell aggregate diameters reached ~150–200 μm. The
concentration of glucose and lactate in the culture media
also suggested a reduced growth after day 3, when the pH of
the media drop to ~6.75 as cell density increased, which
might be harmful for the hiPSC lines that are more sensitive
to changes in pH and influence the expansion. This issue may
be solved by gradually increasing the culture volume or the
media change frequency. The inclusion of a non-invasive O2
probe-patch made it possible to monitor pO2 levels real-time
without disturbing the flow and the rotation of the impeller
in the glass-ball bioreactor, which are normally difficult to
equip with a standard large O2 probe (Zweigerdt et al., 2011;
Niebruegge et al., 2009).
Using the optimized operating conditions we demonstrate
serial passaging and expansion of two integration-free hiPSC
lines in completely defined xeno-free media in 100-ml
bioreactors. The cells exhibited homogeneous aggregate
formation, steady expansion in their pluripotent state, and
normal karyotype after ~20 passages. Note that one experi-
ment of extended expansion of TNC1 cells in spinner flask
(p30 + 6 + 21) showed abnormal karyotype (47, XXY). How-
ever, there is no evidence that it should be attributed to the
suspension culture. In general, recently improved iPSC
culture conditions reduce selective pressure for the growth
of mutated cells that acquire growth advantages. Although
karyotypically abnormal cells were found occasionally after
long-term cultures under both adherent and suspension
conditions, the frequency is low (5% of tested batches of
hiPSCs and hESCs). The standard karyotyping or other geno-
typing methods like what we performed here will remainFigure 7 Schematic presentation of the cryopreservation and sca
and the yield of hiPSCs are presented as approximate amount. Drawnecessary to manage this inherent issue of long-term cell
cultures.
Undifferentiated hiPSCs expanded in bioreactors retained
their potential of spontaneous and directed hematopoietic
differentiation comparable to cells cultured via adherent
culture. The transformation from day 2 or day 3 cell
aggregates to EBs for spontaneous differentiation in the
spinner flask demonstrates the possibility to use this system
for a continuous bioprocess that begins with a large-scale
expansion and directed differentiation in one single batch.
Interestingly, although comparable amount of HPCs and CFU
was derived from hiPSCs expanded in bioreactor as in
adhesion, HPCs derived from TNC1 in bioreactor generated
a considerably higher proportion of cells in erythroid lineage
rather than in myelocyte lineage. Further studies are needed
to reveal the significance and the mechanism underlying the
contribution of hydrodynamic forces to hPSC differentiation
in suspension. Studies of hematopoietic differentiation in
spinner flasks are ongoing.
The development of a single-cell cryopreservation proto-
col concluded the establishment of our chemically defined
xeno-free suspension culture system. For continuous expan-
sion, UL-SF protocol was the preferred method for recovery
with small number of hiPSCs from cryopreservation. The
hiPSCs can be directly thawed in a spinner flask; cells
cultured in a spinner flask can be transferred back to
VNT-N-coated surface for the applications that require
adhesion culture, indicating good flexibility of the system.
The single-cell cryopreservation protocol and the suspension
culture system can significantly reduce the workload when
handling cells in the scale required for translational uses.
Furthermore, this xeno-free protocol of cryopreservation
and recovery was theoretically proved to be compliant to a
scale-up strategy for hiPSCs in suspension and under cGMPle-up expansion of hiPSCs in xeno-free culture system. The days
ing not to scale.
1115Scalable expansion of human induced pluripotent stem cellscondition, allowing a yield of ~1 × 109 cells within 20 days
after thawing of 1 × 106 frozen cells (Fig. 7). The scale-up
strategy, which includes multiple xeno-free processes,
employs 100-ml and 1-l spinner flasks, enabling the transition
from lab scale to pilot scale of hiPSC expansion. The CFD
simulation of the 1-l spinner flask (Supplementary Fig. S5)
equipped with two glass-ball stirring pendulums (such as one
from Integra Bio-sciences) indicated that it could be scalable
using 1-l spinner flasks toward clinically relevant quantities
of hiPSCs from a single batch. The simulation revealed a
steady flow at the highest agitating speed of 75 rpm and an
even lower maximum shear stress (0.047 N/m2) compared to
the 100-ml spinner flask in steady state. On one hand, the
distance between the farthest points of the pendulums and
the spin axis (r = 38.9 mm in Supplementary Fig. S5,
equivalent to impeller radius of paddle impellers) in the 1-l
spinner flask is not much longer than the 100-ml spinner flask
(r = 28.2 mm); thus, the highest velocity in 1-l spinner flasks
is not much higher than that in 100-ml spinner flasks
(vmax,1 l = 0.309 m/s vs. vmax,100 ml = 0.224 m/s). On the
other hand, there is much more space between the
pendulums to the flask wall in the radial direction (l in
Supplementary Fig. S5, l1 l = 29.1 mm vs. l100 ml = 3.5 mm).
This causes a more moderate drop of velocity from the
maximum at the far reach of the pendulums to zero at the
flask wall in 1-l spinner flask compared to the 100-ml spinner
flask, leading to a significant decrease of the gradient of
velocity, dvz/dx, which contributes to the majority of the
shear stress. Before reaching steady state, stepping acceler-
ation could be used to protect the cells from sudden exposure
to high-speed flow. Also, the liquid level of 600-ml medium in
the 1-l spinner flask is similar to that of 60-ml medium in the
100-ml spinner flask, which was proven in this study not to
cause any reduced O2 transport (from Fig. 3g). While
optimization of the agitation speed should be performed for
different hiPSC lines to support appropriate size aggregate
formation (for example, diameter of 50–80 μm after 24 h),
this direct scale-up process in 1-l spinner flasks with the same
well-designed system should be attainable.
Another practical advantage of the system is its relative
low cost. The high price of current commercially available
serum-free media such as StemPro and mTeSR always
hinders the universal application of the scale-up technolo-
gies for hiPSC expansion, especially for xeno-free media
when albumin is required in the medium (Chen et al., 2011).
The simplicity of the medium dramatically cuts down the
price (~30%–60%) and makes it possible for bulk production
in academic laboratories and cGMP-compliant institutions.
In conclusion, we established a reproducible approach for
rapid, economic, and scalable expansion of hiPSCs in xeno-
free condition to meet the demand of practical research and
clinical applications. The complete elimination of compo-
nents from animal sources and remarkably reduced cost of
this system provide a reliable technology for scale-up of
hiPSC expansion and take a significant step toward the
realization of stem cell therapies.Author contributions
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